BlackRock’s Guardion Health Sciences, Inc. Common Stock GHSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-10,030
| Closed | -$55.6K | – | 5513 |
|
|
2024
Q3 | $55.6K | Hold |
10,030
| – | – | ﹤0.01% | 4791 |
|
|
2024
Q2 | $101K | Hold |
10,030
| – | – | ﹤0.01% | 4702 |
|
|
2024
Q1 | $90.5K | Hold |
10,030
| – | – | ﹤0.01% | 4755 |
|
|
2023
Q4 | $53.6K | Hold |
10,030
| – | – | ﹤0.01% | 4956 |
|
|
2023
Q3 | $74K | Hold |
10,030
| – | – | ﹤0.01% | 4919 |
|
|
2023
Q2 | $78K | Hold |
10,030
| – | – | ﹤0.01% | 4989 |
|
|
2023
Q1 | $61.3K | Buy |
10,030
+1
| +0% | +$7 | ﹤0.01% | 5081 |
|
|
2022
Q4 | $72.8K | Hold |
10,029
| – | – | ﹤0.01% | 5137 |
|
|
2022
Q3 | $69K | Hold |
10,029
| – | – | ﹤0.01% | 5285 |
|
|
2022
Q2 | $73K | Sell |
10,029
-1,181
| -11% | -$10.3K | ﹤0.01% | 5324 |
|
|
2022
Q1 | $130K | Sell |
11,210
-53
| -0.5% | -$1.08K | ﹤0.01% | 5226 |
|
|
2021
Q4 | $364K | Buy |
11,263
+32
| +0.3% | +$1.72K | ﹤0.01% | 4967 |
|
|
2021
Q3 | $713K | Sell |
11,231
-208
| -2% | -$13.8K | ﹤0.01% | 4661 |
|
|
2021
Q2 | $1.01M | Sell |
11,439
-1,106
| -9% | -$96.1K | ﹤0.01% | 4515 |
|
|
2021
Q1 | $1.5M | Buy |
+12,545
| New | +$2.53M | ﹤0.01% | 4387 |
|
|
2020
Q2 | – | Sell |
-594
| Closed | -$81K | – | 5164 |
|
|
2020
Q1 | $81K | Buy |
594
+551
| +1,281% | +$58.3K | ﹤0.01% | 4396 |
|
|
2019
Q4 | $3K | Buy |
43
+41
| +2,050% | +$3.92K | ﹤0.01% | 4855 |
|
|
2019
Q3 | $0 | Hold |
2
| – | – | ﹤0.01% | 5104 |
|
|
2019
Q2 | $1K | Buy |
+2
| New | +$1.18K | ﹤0.01% | 4996 |
|
BlackRock's GHSI Position: Q4 2024 in Review
BlackRock sold out of Guardion Health Sciences, Inc. Common Stock (GHSI) in Q4 2024, closing a stake of 10,030 shares — an estimated $55.6K sold.
BlackRock first reported a position in GHSI in Q2 2019 and held it in 19 quarters. The position peaked at $1.5M in Q1 2021. 0 funds tracked by Wall St. Rank hold GHSI as of Q4 2024.
- BlackRock reported no remaining Guardion Health Sciences, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
- BlackRock sold 10,030 Guardion Health Sciences, Inc. Common Stock shares in Q4 2024, an estimated $55.6K.
- BlackRock first reported a position in Guardion Health Sciences, Inc. Common Stock in Q2 2019 and held it in 19 quarters.
- BlackRock's Guardion Health Sciences, Inc. Common Stock position peaked at $1.5M in Q1 2021.
- 0 funds tracked by Wall St. Rank held Guardion Health Sciences, Inc. Common Stock as of Q4 2024.
Based on BlackRock's 13F filing for Q4 2024, filed 7 Feb 2025.